Altman Peter's Form 4 filing
BioCardia, Inc. (BCDA) · filed Apr 22, 2026
- Accession no.
- 0001437749-26-013052
- Filed
- Apr 22, 2026
- Trade date
- Apr 20-21, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.23K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altman PeterCIK 0001647542 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | PPurchaseAcquired | +600 | $1.23 | +$738 | 275,366 | Direct | |
| Apr 21, 2026 | Common Stock | PPurchaseAcquired | +400 | $1.23 | +$492 | 275,766 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.